Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
  1. 4 Open-market buy Chief Operating Officer bought 42 shares at an average $7.88 ($331)
  2. 4 Grant or award Trachtenberg Eric acquired 61,000 shares (grant or award)
  3. 4 Grant or award Chief Scientific Officer acquired 61,000 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 81,000 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 178,300 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 61,000 shares (grant or award)
  7. 4 Grant or award Trachtenberg Eric acquired 16,000 shares (grant or award)
  8. 4 Grant or award Director acquired 20,000 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 16,000 shares (grant or award)
  10. 4 Grant or award Director acquired 20,000 shares (grant or award)
  11. 4 Grant or award Director acquired 20,000 shares (grant or award)
  12. 4 Exercise or conversion Director acquired 4,824 shares (option exercise)
  13. 4 Grant or award Chief Executive Officer acquired 49,560 shares (grant or award)
  14. 4 Grant or award Director acquired 20,000 shares (grant or award)
  15. 4 Other acquisition Director acquired 2,361 shares (other)
  16. 4 Grant or award Director acquired 20,000 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 19,000 shares (grant or award)
  18. 4 Grant or award Director acquired 28,000 shares (grant or award)
  19. 4 Grant or award Chief Scientific Officer acquired 16,000 shares (grant or award)
  20. 4 Grant or award Chief Operating Officer acquired 19,000 shares (grant or award)

Page 9 of 15 · 288 filings